Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Recent Analysis Shows Abercrombie & Fitch, DaVita, W.W. Grainger, Ingredion, FirstEnergy, and Second Sight Medical Products Market Influences — Renewed Outlook, Key Drivers of Growth

DVA, GWW, INGR, FE, VANI

NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Abercrombie & Fitch Company (NYSE:ANF), DaVita Inc. (NYSE:DVA), W.W. Grainger, Inc. (NYSE:GWW), Ingredion Incorporated (NYSE:INGR), FirstEnergy Corporation (NYSE:FE), and Second Sight Medical Products, Inc. (NASDAQ:EYES), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

ANF DOWNLOAD: http://MarketSourceResearch.com/register/?so=ANF
DVA DOWNLOAD: http://MarketSourceResearch.com/register/?so=DVA
GWW DOWNLOAD: http://MarketSourceResearch.com/register/?so=GWW
INGR DOWNLOAD: http://MarketSourceResearch.com/register/?so=INGR
FE DOWNLOAD: http://MarketSourceResearch.com/register/?so=FE
EYES DOWNLOAD: http://MarketSourceResearch.com/register/?so=EYES

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Abercrombie & Fitch Company (NYSE:ANF), DaVita Inc. (NYSE:DVA), W.W. Grainger, Inc. (NYSE:GWW), Ingredion Incorporated (NYSE:INGR), FirstEnergy Corporation (NYSE:FE), and Second Sight Medical Products, Inc. (NASDAQ:EYES) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed January 16th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

ABERCROMBIE & FITCH COMPANY (ANF) REPORT OVERVIEW

Abercrombie & Fitch's Recent Financial Performance

For the three months ended October 31st, 2018 vs October 31st, 2017, Abercrombie & Fitch reported revenue of $861.19MM vs $859.11MM (up 0.24%) and analysts estimated basic earnings per share $0.36 vs $0.15 (up 140.00%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, Abercrombie & Fitch reported revenue of $3,492.69MM vs $3,326.74MM (up 4.99%) and analysts estimated basic earnings per share $0.10 vs $0.06 (up 66.67%). Analysts expect earnings to be released on March 6th, 2019. The report will be for the fiscal period ending January 31st, 2019. The reported EPS for the same quarter last year was $1.38. The estimated EPS forecast for the next fiscal year is $0.98 and is expected to report on March 6th, 2019.

To read the full Abercrombie & Fitch Company (ANF) report, download it here: http://MarketSourceResearch.com/register/?so=ANF

-----------------------------------------

DAVITA INC. (DVA) REPORT OVERVIEW

DaVita's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, DaVita reported revenue of $2,847.33MM vs $2,765.07MM (up 2.97%) and analysts estimated basic earnings per share -$0.82 vs -$1.14. For the twelve months ended December 31st, 2017 vs December 31st, 2016, DaVita reported revenue of $10,876.63MM vs $10,707.47MM (up 1.58%) and analysts estimated basic earnings per share $3.52 vs $4.36 (down 19.27%). Analysts expect earnings to be released on February 12th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.92. The estimated EPS forecast for the next fiscal year is $4.74 and is expected to report on February 12th, 2019.

To read the full DaVita Inc. (DVA) report, download it here: http://MarketSourceResearch.com/register/?so=DVA

-----------------------------------------

W.W. GRAINGER, INC. (GWW) REPORT OVERVIEW

W.W. Grainger's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, W.W. Grainger reported revenue of $2,831.43MM vs $2,636.00MM (up 7.41%) and analysts estimated basic earnings per share $1.84 vs $2.80 (down 34.29%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, W.W. Grainger reported revenue of $10,424.86MM vs $10,137.20MM (up 2.84%) and analysts estimated basic earnings per share $10.07 vs $9.94 (up 1.31%). Analysts expect earnings to be released on January 24th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $2.94. The estimated EPS forecast for the next fiscal year is $17.93 and is expected to report on January 24th, 2019.

To read the full W.W. Grainger, Inc. (GWW) report, download it here: http://MarketSourceResearch.com/register/?so=GWW

-----------------------------------------

INGREDION INCORPORATED (INGR) REPORT OVERVIEW

Ingredion's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Ingredion reported revenue of $1,450.00MM vs $1,485.00MM (down 2.36%) and basic earnings per share $1.33 vs $2.31 (down 42.42%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ingredion reported revenue of $5,832.00MM vs $5,704.00MM (up 2.24%) and analysts estimated basic earnings per share $7.21 vs $6.70 (up 7.61%). Analysts expect earnings to be released on February 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $1.73. The estimated EPS forecast for the next fiscal year is $7.89 and is expected to report on February 5th, 2019.

To read the full Ingredion Incorporated (INGR) report, download it here: http://MarketSourceResearch.com/register/?so=INGR

-----------------------------------------

FIRSTENERGY CORPORATION (FE) REPORT OVERVIEW

FirstEnergy's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, FirstEnergy reported revenue of $3,064.00MM vs $2,910.00MM (up 5.29%) and analysts estimated basic earnings per share -$1.02 vs $0.89. For the twelve months ended December 31st, 2017 vs December 31st, 2016, FirstEnergy reported revenue of $14,017.00MM vs $14,562.00MM (down 3.74%) and analysts estimated basic earnings per share -$3.88 vs -$14.49. Analysts expect earnings to be released on February 19th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.71. The estimated EPS forecast for the next fiscal year is $2.55 and is expected to report on February 19th, 2019.

To read the full FirstEnergy Corporation (FE) report, download it here: http://MarketSourceResearch.com/register/?so=FE

-----------------------------------------

SECOND SIGHT MEDICAL PRODUCTS, INC. (EYES) REPORT OVERVIEW

Second Sight Medical Products' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Second Sight Medical Products reported revenue of $2.25MM vs $1.61MM (up 39.50%) and analysts estimated basic earnings per share -$0.12 vs -$0.12. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Second Sight Medical Products reported revenue of $7.96MM vs $3.99MM (up 99.85%) and analysts estimated basic earnings per share -$0.53 vs -$0.84. Analysts expect earnings to be released on March 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.16. The estimated EPS forecast for the next fiscal year is -$0.44 and is expected to report on March 6th, 2019.

To read the full Second Sight Medical Products, Inc. (EYES) report, download it here: http://MarketSourceResearch.com/register/?so=EYES

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today